Eugènia Pujol defended her PhD thesis (2 February 2021)
Eugènia Pujol successfully defended her PhD Thesis entitled “Urea-based compounds for a broad range of therapeutic applications”, supervised by Dr.…
February 5, 2021
News
+ info
Andreea Turcu defended her PhD thesis (28 January 2021)
Andreea Turcu successfully defended her PhD Thesis entitled “Antagonistas de receptores ionotrópicos como potenciales terapias en la enfermedad de Alzheimer”,…
February 2, 2021
A World of Possibilities
Galenicum has been collaborating with the UB de Farmàcia i Ciències de l’Alimentació for the past years, and most recently…
January 14, 2021
Eugènia Pujol awarded with a Validate 2020 project from “La Caixa” Foundation to fight neuropathic pain with first-in-class dual agents
A project led by Eugènia Pujol, a PhD student from Santiago Vázquez’s group, has been selected by “la Caixa” Foundation as…
December 19, 2020
Researchers identify an action mechanism for a drug against Alzheimer‘ disease
A study conducted on mice published in the journalGeroscience has identified the action mechanism of a promising compound against Alzheimer’s disease,…
December 10, 2020
UB team to expand frontiers of multicomponent reaction-based molecular synthesis
The synthesis of complex molecules such as drugs, requires a process that sometimes involves several phases that increase its cost…
November 9, 2020
Welcome to the group to Noemí, Pau and Ainoa
We are pleased to welcome Noemí Martínez, Pau Nadal and Ainoa Sánchez as the newest members of the Medicinal Chemistry…
November 6, 2020
Sandra Codony defended her PhD thesis (18 September 2020)
Sandra Codony successfully defended her PhD Thesis entitled “From the design to the in vivo evaluation of novel sEH inhibitors”,…
October 28, 2020
Diego Muñoz-Torrero and Santiago Vázquez have been granted a valorization project to develop a new class of anti-Alzheimer agents
A project of our group devoted to the development of novel dual acting compounds that hit two biological targets with…
October 28, 2020
Offer PhD contract FPI
Rodolfo Lavilla and Carmen Escolano team offers a predoctoral contract: an exciting research project on novel #MulticomponentReactions and their applications…
October 10, 2020
Andreea L. Turcu was awarded a poster prize at I-YMC-VMEET
We are delighted to announce that Andreea L. Turcu (S. Vázquez’s group), was awarded a poster prize by ChemMedChem for…
July 28, 2020
MedChemPhar study identifies a new pharmacological target against Alzheimer’s disease: Post in media press
A UB study published in the journal Neurotherapeutics has validated a new pharmacological target for Alzheimer’s disease. The results show the inhibition…
July 25, 2020
YMCVMEET virtual poster session
Proud of the multidisciplinary work of groups from seven institutions in #IYMCVMEET virtual poster session. Thank you to @DCFSCI Medicinal…
July 20, 2020
The 6th Science Fest of the University of Barcelona, at home
The 6th Science Fest of the University of Barcelona reaches everyone in a different way, since the COVID-19 health crisis…
May 10, 2020
Researchers design a new family of molecules with high affinity to join altered receptors in neurodegenerative diseases
An article published in the Journal of Medicinal Chemistry shows a new family of molecules with high affinity to join imidazoline receptors,…
April 1, 2020
“Inhibitors of soluble epoxide hydrolase to face Niemann-Pick’s C disease”, was awarded by Impulsa Llavor program 2018. Its aim is to assess new drugs against the Niemann-Pick disease type C.
Dr Christian Griñán-Ferré and Dr Mercè Pallàs research group obtained a grant worth 20,000 euros for the ‘Inhibitors of soluble…
March 24, 2020
Dr Muñoz -Torrero chairs the 2nd Molecules Medicinal Chemistry Symposium – Facing Novel Challenges in Drug Discovery” (MMCS2019)
The conference will held in Barcelona (15th-17th, May), and is organized by MDPI, the publisher of the open-access journal Molecules and follows the…
March 20, 2020
Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model” selected as the featured cover paper for Aging-US.
Aging-US selected Griñán-Ferré contribution Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an…
March 19, 2020